Staar Surgical (STAA) Capital Expenditures (2010 - 2026)

Staar Surgical (STAA) has 17 years of Capital Expenditures data on file, last reported at $443000.0 in Q2 2026.

• For the quarter ending Q2 2026, Capital Expenditures fell 69.82% year-over-year to $443000.0; the trailing twelve-month figure through Apr 2026 stood at $4.8 million (down 75.61% YoY), and the FY2026 full-year result was $5.8 million, down 75.12% from the prior year.
• Capital Expenditures for Q2 2026 stood at $443000.0, down from $1.7 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $9.2 million in Q3 2023 and bottomed at $443000.0 in Q2 2026.
• The 5-year median for Capital Expenditures is $3.1 million (2023), against an average of $3.9 million.
• The widest annual swing landed in 2024, when Capital Expenditures jumped 106.9%; it then plunged 85.83% in 2025.
• A 5-year view of Capital Expenditures shows it stood at $4.0 million in 2022, then slipped by 23.28% to $3.1 million in 2023, then surged by 85.4% to $5.7 million in 2024, then slumped by 84.58% to $883000.0 in 2025, then tumbled by 49.83% to $443000.0 in 2026.
• The last three Capital Expenditures figures came in at $443000.0 (Q2 2026), $1.7 million (Q1 2026), and $883000.0 (Q3 2025), per Business Quant data.

Peer Comparison